Ipsen

Ipsen is a global, mid-sized biopharmaceutical company founded in 1929. It discovers, develops and brings specialty care medicines to patients, with research and innovation focused on areas of high unmet medical need. The company employs more than 5,000 professionals and operates in 88 countries across five continents, with global hubs in the United States, France and the United Kingdom.

Its work is concentrated on three therapeutic areas: Oncology, Rare Disease and Neuroscience. Each portfolio comprises medicines aimed at areas of high unmet medical need. The research and development pipeline is intended to deliver at least one new molecular entity or meaningful indication every year.

Operating across 88 jurisdictions in a heavily regulated industry, Ipsen works within the pharmaceutical, healthcare, oncology, rare disease and neuroscience sectors. The company describes its culture as entrepreneurial, pairing global scale with the agility to move quickly and a mission centred on improving patients' lives.